VANGUARD GROUP INC - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 50 filers reported holding EVELO BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$572,525
-88.8%
3,168,3750.0%0.00%
Q4 2022$5,101,084
-24.3%
3,168,375
-1.7%
0.00%
Q3 2022$6,735,000
+134.7%
3,222,420
+136.9%
0.00%
Q2 2022$2,870,000
-45.2%
1,360,322
-11.9%
0.00%
Q1 2022$5,235,000
-38.9%
1,544,518
+9.4%
0.00%
Q4 2021$8,571,000
-18.6%
1,411,816
-5.6%
0.00%
Q3 2021$10,532,000
-48.1%
1,495,887
+1.3%
0.00%
-100.0%
Q2 2021$20,291,000
+40.1%
1,476,784
+9.1%
0.00%
Q1 2021$14,479,000
+3.8%
1,353,224
+17.3%
0.00%
Q4 2020$13,952,000
+198.5%
1,154,066
+30.1%
0.00%
Q3 2020$4,674,000
+9.3%
886,960
+1.6%
0.00%
Q2 2020$4,277,000
+167.0%
873,054
+104.6%
0.00%
Q1 2020$1,602,000
-7.3%
426,712
+0.2%
0.00%
Q4 2019$1,729,000
-33.8%
425,768
-0.5%
0.00%
Q3 2019$2,610,000
-33.2%
427,915
-1.7%
0.00%
Q2 2019$3,909,000
+13.2%
435,335
+0.9%
0.00%
Q1 2019$3,453,000
-15.5%
431,650
+37.5%
0.00%
Q4 2018$4,084,000
+39.9%
313,869
+30.9%
0.00%
Q3 2018$2,920,000
+269.6%
239,792
+258.0%
0.00%
Q2 2018$790,00066,9880.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders